This source explains that unlike other nutrients, amino acids contain nitrogen, which poses a unique challenge during metabolic breakdown. Because the body cannot store surplus amino acids as it does with fats or sugars, it must either use them for protein synthesis or dismantle them for energy. When these molecules are broken down, the nitrogen is converted into ammonia, a toxic byproduct that requires the urea cycle for safe elimination. The remaining carbon skeletons are repurposed for energy production. Ultimately, the carbon skeletons are converted to either glucose or acetyl CoA. The latter two molecules are oxidized to CO2 to produce energy.

The provided source explains that **amino acids** are distinct from other nutrients because they contain **nitrogen** and cannot be **stored for future use** by the body. While these molecules primarily function as building blocks for **cellular proteins** and essential compounds like **neurotransmitters**, any surplus is immediately broken down for **energy production**. A critical byproduct of this metabolic process is **ammonia**, a toxic substance that the body must neutralize through the **urea cycle**. This ensures that the **carbon skeletons** of excess amino acids are safely repurposed for fuel while harmful nitrogenous waste is eliminated. Ultimately, the text highlights the unique chemical pathways required to manage **protein metabolism** compared to the storage of fats or sugars.

The provided source explores the physiological relationship between insulin resistance and dyslipidemia, focusing on how specific enzymes disrupt blood lipid levels. It explains that this condition arises from a functional imbalance between two key lipases responsible for processing fats. Specifically, a reduction in lipoprotein lipase activity prevents the body from clearing triglycerides, causing them to accumulate in the bloodstream. Simultaneously, an increase in hormone-sensitive lipase triggers the excessive release of stored fatty acids from fat cells into the plasma. Together, these enzymatic shifts produce the elevated fat concentrations typically observed in metabolic disorders. This overview highlights the underlying biochemical mechanisms that drive lipid imbalances in insulin-resistant individuals.